스타틴 의약품의약가인하 효과 및 약물 교체 관련 요인: 건강보험심사평가원 환자표본자료를 이용한 분석
분야
의약학 > 예방의학및보건학
저자
이혜재 ( Hye Jae Lee ) , 이태진 ( Tae Jin Lee )
발행기관
한국보건행정학회
간행물정보
보건행정학회지 2013년, 제23권 제2호, 112~123페이지(총12페이지)
파일형식
2c301011.pdf [무료 PDF 뷰어 다운로드]
  • ※ 본 자료는 참고용 논문으로 수정 및 텍스트 복사가 되지 않습니다.
  • 구매가격
    5,200원
    적립금
    156원 (구매자료 3% 적립)
    이메일 발송  스크랩 하기
    자료 다운로드  네이버 로그인
    영문초록
    Background: Under the risk of financial sustainability of National Health Insurance, Korean government attempted a series of regu­lations over pharmaceutical prices. The first price-cut was implemented to the hyperlipidemial treatments, and the prices of statins were reduced on 15th, April in 2009. The purposes of this study are 1) to investigate the impact of this price-cut on pharmaceutical expenditure, and 2) to identify the factors associated with drug-switch among statins. Methods: Using the national patients sample data, this study conducted time series analysis on the expenditures, prices, and vol­umes of statin drugs. To understand the factors associated with drug-switch, the multinomial log it model was analyzed at the pa­tients level. Results: The results of time series analysis demonstrated that the price-cut of hyperlipidemic medicines did not lead to the reduced expenditure, suggesting the increased volume was the major cause. The multinomiallogit analysis identified the switch of health­care provider as the significant factor that was highly associated with drug-switch, implying the physicians` preference was the ma­jor motivation of drug-switch. Conclusion: Without control of utilization, price regulation itself could not reduce pharmaceutical expenditure. This suggests that the pharmaceutical regulations should be implemented on the basis of understanding of provider behaviors. The findings of this study will form the first step for further empirical studies.
    사업자등록번호 220-87-87785 대표.신현웅 주소.서울시 서초구 방배로10길 18, 402호 대표전화.070-8809-9397
    개인정보책임자.박정아 통신판매업신고번호 제2017-서울서초-1765호 이메일 help@reportshop.co.kr
    copyright (c) 2009 happynlife. steel All reserved.